Sort
30,917 grants matching “tumor microenvironment”
Innate Factors in Tumor Antigen Cross-Presentation
$272,268Thomas F Gajewski · University Of Chicago · P01 · FY2009 · CA
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
$272,224Theresa A Guise · Indiana University Indianapolis · R01 · FY2011 · CA
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
$272,224Theresa A Guise · Indiana University Indianapolis · R01 · FY2012 · CA
Exploiting Chromatin Alteration to Treat Clear Cell Carcinoma
$272,150William G Kaelin · Beth Israel Deaconess Medical Center · P50 · FY2019 · CA
CELL MEDIATED IMMUNITY IN MAMMARY TUMOR MODELS
$272,102University Of Miami School Of Medicine · R01 · FY2001 · CA
Research Project-Obesity in Cancer: The role of obesity in NF-kB-induced cancer stem cell-like phenotype and its implication in ovarian cancer tumorigenesis and chemoresistance
$272,095Carrie Danielle House · San Diego State University · U54 · FY2022 · MD
Multiscale systems biology modeling to exploit tumor-stromal metabolic crosstalk in colorectal cancer
$272,093Stacey Deleria Finley · University Of Southern California · U01 · FY2022 · CA
Novel Strategies for Immunotherapy of Cancer
$272,032Rongfu Wang · Methodist Hospital Research Institute · R01 · FY2015 · CA
Novel Strategies for Immunotherapy of Cancer
$272,032Rongfu Wang · Methodist Hospital Research Institute · R01 · FY2011 · CA
Enhanced Immunity Inside of Tumor Microenvironment
$272,019Yang-Xin Fu · University Of Chicago · R01 · FY2006 · CA
Regulation of Snail in breast cancer progression and metastasis
$272,014Binhua P Zhou · University Of Kentucky · R01 · FY2014 · CA
Targeting Endoplasmic Reticulum Stress Sensor IRE1 to Enhance Chemotherapy Sensitivity in MYC-driven breast cancer
$272,000Xi Chen · Baylor College Of Medicine · P50 · FY2024 · CA
Defining pro-metastatic and endothelial-regulatory roles for LIN28B in hepatocellular carcinoma
$271,934Joseph Wang Franses · Massachusetts General Hospital · K08 · FY2022 · CA
Ongoing inflammation following chemotherapy induces immunosuppression
$271,855Chuanlin Ding · University Of Louisville · P20 · FY2021 · GM
OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE
$271,819Cliona M Rooney · Baylor College Of Medicine · P01 · FY2011 · CA
VEGF mRNA Expression Mechanisms in Hypoxia
$271,728Kevin P. Claffey · University Of Connecticut Sch Of Med/Dnt · R01 · FY2010 · CA
VEGF mRNA Expression Mechanisms in Hypoxia
$271,728Kevin P. Claffey · University Of Connecticut Sch Of Med/Dnt · R01 · FY2009 · CA
VEGF mRNA Expression Mechanisms in Hypoxia
$271,728Kevin P. Claffey · University Of Connecticut Sch Of Med/Dnt · R01 · FY2007 · CA
VEGF mRNA Expression Mechanisms in Hypoxia
$271,728Kevin P. Claffey · University Of Connecticut Sch Of Med/Dnt · R01 · FY2008 · CA
Chemoradiotherapy for Multiple Myeloma
$271,722Apollina Goel · University Of Iowa · R01 · FY2011 · CA
Chemoradiotherapy for Multiple Myeloma
$271,722Apollina Goel · University Of Iowa · R01 · FY2012 · CA
Design, Synthesis, and Evaluation of ant-Glioblastoma Agents
$271,698Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · GM
Overcoming resistance to cancer immunotherapy by targeting MDSC-derived adenosine
$271,697Kavitha Yaddanapudi · University Of Louisville · P20 · FY2021 · GM
Bioinformatics, Biostatistics, and Image Analyses Core
$271,674Xiaole Shirley Liu · Massachusetts General Hospital · P01 · FY2021 · CA
Bioinformatics, Biostatistics, and Image Analyses Core
$271,674Xiaole Shirley Liu · Massachusetts General Hospital · P01 · FY2020 · CA